Literature DB >> 10777660

Determination of X-chromosome inactivation status using X-linked expressed polymorphisms identified by database searching.

R Kutsche1, C J Brown.   

Abstract

The large number of redundant sequences available in nucleotide databases provides a resource for the identification of polymorphisms. Expressed polymorphisms in X-linked genes can be used to determine the inactivation status of the genes, and polymorphisms in genes that are subject to inactivation can then be used as tools to examine X-chromosome inactivation status in heterozygous females. In this study, we have identified six new X-linked single-nucleotide polymorphisms and determined the inactivation status of these genes by examination of expression patterns in female cells previously demonstrated to have skewed inactivation, as well as by analysis of somatic cell hybrids retaining the inactive human X chromosome. Expression was seen from both alleles in females heterozygous for the RPS4X gene, confirming the previously reported expression from the inactive X chromosome. Expression of only a single allele was seen in females heterozygous for polymorphisms in the BGN, TM4SF2, ATP6S1, VBP1, and PDHA1 genes, suggesting that these genes are subject to X-chromosome inactivation. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777660     DOI: 10.1006/geno.2000.6153

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  2 in total

1.  Mutation analysis of subjects with 46, XX sex reversal and 46, XY gonadal dysgenesis does not support the involvement of SOX3 in testis determination.

Authors:  H N Lim; G D Berkovitz; I A Hughes; J R Hawkins
Journal:  Hum Genet       Date:  2000-11-14       Impact factor: 4.132

2.  ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction.

Authors:  F Stephen Hodi; Jan C Schmollinger; Robert J Soiffer; Ravi Salgia; Thomas Lynch; Jerome Ritz; Edwin P Alyea; Jihong Yang; Donna Neuberg; Martin Mihm; Glenn Dranoff
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.